Flu Infection at UPHS

Enrolling By Invitation
99 years or below
All
Phase N/A
50 participants needed
1 Location

Brief description of study

Primary: Determine if influenza infection elicits antibodies that bind to and neutralize older influenza virus strains. Secondary: Characterize B cell and T cell responses to influenza virus infection. Specificity, quantity, and quality of serum antibodies to influenza viruses using assays including but not limited to FRNT, ELISA, ELLA, and HAI. We will compare antibody titers between different strains to understand if memory of de novo immune responses are generated following influenza infection based on inferred influenza exposure history. B cell and T cell specificity and functionality will be assessed using assays including but not limited to flow cytometry, ELISpot, and genetic lineage analyses. Results will help us to understand how influenza infection influences the generation of memory and de novo immune responses.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research
  • Age: 99 years or below
  • Gender: All

TBD

Updated on 17 Jun 2025. Study ID: 24-2105
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Office of Clinical Research